by Bin Li, James Smith, PhD, Salvatore T. Butera, DVM, PhD, and Dennis L. Ellenberger, PhD
Volume 5, Issue 1 (Spring 2006)
As human immunodeficiency virus type-1 (HIV-1) continues to spread around the world, scientists are actively pursuing effective vaccines against the infectious disease that results in AIDS. A number of vaccine designs have been developed, including plasmid DNA constructs encoding HIV proteins. One advantage of DNA vaccination is that after the uptake of the plasmid by the host cells, the encoded antigens are expressed in the native conformation and allow authentic immunological processing of the antigen. Another advantage of DNA vaccines is that they can be repeatedly administered without vector-directed immunity limiting the efficacy of the boost. DNA vaccines alone can induce both humoral and cellular immune responses and provide modest protection against disease progression in the preclinical, nonhuman primate model when challenged with simian immunodeficiency virus (SIV)…
Citation:
Li B, Smith J, Butera ST, Ellenberger DL. Effects of Mutation in Protease on the Production of Human Immunodeficiency Virus Type-1 Virus-Like Particles. BioProcess J, 2006; 5(1): 43-51. https://doi.org/10.12665/J51.Butera